leisure time -WSS

leisure time

author：explore 2025-08-26 23:48:27 - browse：14227

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

In an abrupt change of course from plans earlier in the month, at-home test maker Cue Health is laying off all of its employees and shutting down as of Friday, May 24.

The company, which grew to prominence during the Covid-19 pandemic as the maker of one of the only molecular at-home tests for the virus, has been teetering on the edge of insolvency for months. The shutdown, first reported by the San Diego Union-Tribune, comes just over a week after the FDA warned consumers not to use Cue’s only FDA-authorized product, a Covid-19 test kit.

Cue had previously notified 49% of its workers on May 1 that they would be laid off from the company, effective July 1. But in a WARN notice filed with California state regulators on May 20, chief human resources officer Allison Blackwell said that due to the “fluid nature of this situation,” all U.S. employees who had not already received notice of termination would be receiving one. All employees will receive their last paychecks on May 24, the notice said.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

WSS

Biden administration sends mixed signals on US soldier who crossed into North Korea

The woman behind the Dana Farber

A strong 6.5

What causes an itch? Researchers may have solved the mystery

Supreme Court wrestles with OxyContin maker's bankruptcy deal

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

entertainment

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Congenital heart disease patients face new threat of heart failure

DIEP, the 'gold standard' of breast reconstruction, is under threat

Pfizer plans to depart BIO

Apple is now the first public company to be valued at $3 trillion

FDA approves world's first CRISPR

Moonlake's readout produced a cash windfall. Risks remain

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

Medical leaders decry Supreme Court decision on affirmative action

Study: Hearing aids may slow cognitive decline in those at risk

leisure time

Americans' trust in science, scientist continues decline: Report

Patients' immediate access to test results puts radiologists in a bind

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Johnson & Johnson sues to stop Medicare negotiation

SCOTUS to consider access to abortion pill mifepristone

AI models in health care face new federal disclosure requirements

leisure time

knowledge

hotspot

leisure time